vs
Esperion Therapeutics, Inc.（ESPR）与GDEV Inc.（GDEV）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是GDEV Inc.的1.4倍（$168.4M vs $119.9M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 13.3%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
GDEV Inc.是一家游戏娱乐控股公司，在纳斯达克上市，总部位于塞浦路斯利马索尔。该公司前身为2014年成立的游戏公司Nexters，2023年6月改组为控股集团，是欧洲前五的独立移动游戏企业，旗下拥有Nexters Studio、Cubic Games、Royal Ark、Game Gears、Light Hour Games等工作室，分支机构分布在塞浦路斯、亚美尼亚、哈萨克斯坦等地。
ESPR vs GDEV — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$119.9M
营收增速更快
ESPR
高出130.4%
13.3%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $119.9M |
| 净利润 | — | $16.6M |
| 毛利率 | — | — |
| 营业利润率 | 50.6% | 15.5% |
| 净利率 | — | 13.9% |
| 营收同比 | 143.7% | 13.3% |
| 净利润同比 | — | 13.0% |
| 每股收益（稀释后） | $0.32 | $0.90 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRGDEV
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | — | ||
| Q2 25 | $82.4M | $119.9M | ||
| Q1 25 | $65.0M | — | ||
| Q4 24 | $69.1M | — | ||
| Q3 24 | $51.6M | — | ||
| Q2 24 | $73.8M | $105.8M | ||
| Q1 24 | $137.7M | — |
净利润ESPRGDEV
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | — | ||
| Q2 25 | $-12.7M | $16.6M | ||
| Q1 25 | $-40.5M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | — | ||
| Q2 24 | $-61.9M | $14.7M | ||
| Q1 24 | $61.0M | — |
营业利润率ESPRGDEV
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | — | ||
| Q2 25 | 8.6% | 15.5% | ||
| Q1 25 | -34.0% | — | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -31.0% | — | ||
| Q2 24 | 3.5% | 14.4% | ||
| Q1 24 | 52.5% | — |
净利率ESPRGDEV
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | — | ||
| Q2 25 | -15.4% | 13.9% | ||
| Q1 25 | -62.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | — | ||
| Q2 24 | -83.9% | 13.9% | ||
| Q1 24 | 44.3% | — |
每股收益（稀释后）ESPRGDEV
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.06 | $0.90 | ||
| Q1 25 | $-0.21 | — | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | — | ||
| Q2 24 | $-0.33 | $0.81 | ||
| Q1 24 | $0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $41.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $-129.4M |
| 总资产 | $465.9M | $210.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRGDEV
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | $41.6M | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | $50.8M | ||
| Q1 24 | $226.6M | — |
股东权益ESPRGDEV
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | — | ||
| Q2 25 | $-433.5M | $-129.4M | ||
| Q1 25 | $-426.2M | — | ||
| Q4 24 | $-388.7M | — | ||
| Q3 24 | $-370.2M | — | ||
| Q2 24 | $-344.2M | $-118.7M | ||
| Q1 24 | $-294.3M | — |
总资产ESPRGDEV
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | — | ||
| Q2 25 | $347.1M | $210.2M | ||
| Q1 25 | $324.0M | — | ||
| Q4 24 | $343.8M | — | ||
| Q3 24 | $314.1M | — | ||
| Q2 24 | $352.3M | $282.8M | ||
| Q1 24 | $373.1M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRGDEV
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | — | ||
| Q2 25 | $-31.4M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $-35.0M | — | ||
| Q3 24 | $-35.3M | — | ||
| Q2 24 | $-7.2M | — | ||
| Q1 24 | $53.8M | — |
自由现金流ESPRGDEV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | — | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | — |
自由现金流率ESPRGDEV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
资本支出强度ESPRGDEV
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
现金转化率ESPRGDEV
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GDEV
暂无分部数据
